Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 3.667% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a.) S=C1NC2(CCCC2)Nc2ccccc21
b.) N#Cc1c(-c2cccnc2)c2c([nH]c1=S)CCCC2
c.) CC(=O)Nc1ccc(S(=O)(=O)N2CCCN(S(=O)(=O)c3ccc(NC(C)=O)cc3)CC2)cc1
d.) COCCSc1nc(N)c(NC(=O)c2ccco2)c(=O)[nH]1
Answer: a. S=C1NC2(CCCC2)Nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
S=C1NC2(CCCC2)Nc2ccccc21
S=C1NC2(CCCC2)Nc2ccccc21
spiro[1,3-dihydroquinazoline-2,1'-cyclopentane]-4-thione